Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2025-12-24 @ 2:35 PM
NCT ID:
NCT02362659
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of non-valvular atrial fibrillation during hospitalization.
* Preexisting atrial fibrillation.
* Successful all-comer percutaneous coronary intervention:
Procedural success is defined as a reduction of residual luminal diameter stenosis to \<50% without in-hospital death, AMI or the need for emergency CABG.
* Over 18 years of age
* Able to provide written informed consent
Exclusion Criteria:
* Atrial fibrillation due to reversible causes (e.g., thyrotoxicosis, pericarditis)
* Valvular atrial fibrillation secondary to severe mitral stenosis or prosthetic heart valve
* Women who are of childbearing potential Treatment with other investigational drugs or devices within 30 days before enrolment or planned use of investigational drugs or devices during the study
* Life expectancy \<12 months due to non-cardiac comorbidities
* Active alcohol, drug abuse, psychosocial reasons making study participation impractical
* Severe renal insufficiency (calculated creatinine clearance \< 30 mL/min) or dialysis
* Clinically overt stroke within the last 3 months
* Known hypersensitivity or contraindication to aspirin, clopidogrel, prasugrel, ticagrelor, dabigatran, rivaroxaban, apixaban, edoxaban or warfarin
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02362659
Study Brief:
Protocol Section:
NCT02362659